Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > 60% of the road = 270-days
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(617)
•••
Comment by Lesalpes29on Jul 18, 2022 7:31am
274 Views
Post# 34830675

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:60% of the road = 270-days

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:60% of the road = 270-days
FGPstock wrote:
Skier, we all do and say things that we regret. That is part of life and learning. But when you tell the world, your shareholders, potential investors, etc that you have FDA and Health Canada approval on something when you haven't even applied, that is willful fraud, in my opinion. It is pretty hard to get in trouble with the OSC. We all know roger is currently violating his settlement agreement, Sharizi, Lade and others have confirmed this. I am sure everyone at TLT is more than aware of this as mandel and kristina were by roger's side when this all took place. My position is, he is getting paid as ceo, making the decisions, why jeopardize the trial, shareholders and the repuation of tlt, again...imo, he is already putting the company at risk by being the defacto ceo when it is a clear violation.


Trouble maker from day 1. Be ready, we could see the price going down. A short position to cover. A real shame...
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities